Show simple item record

dc.contributor.authorKarsidag, K
dc.contributor.authorSatman, I
dc.contributor.authorDemirel, HO
dc.contributor.authorDinccag, N
dc.contributor.authorYilmaz, MT
dc.contributor.authorSalman, S
dc.contributor.authorSalman, F
dc.contributor.authorYilmaz, Y
dc.contributor.authorOzer, E
dc.contributor.authorSengul, A
dc.date.accessioned2021-03-04T09:24:44Z
dc.date.available2021-03-04T09:24:44Z
dc.date.issued2001
dc.identifier.citationSalman S., Salman F., Satman I., Yilmaz Y., Ozer E., Sengul A., Demirel H., Karsidag K., Dinccag N., Yilmaz M., "Comparison of acarbose and gliclazide as first-line agents in patients with type 2 diabetes", CURRENT MEDICAL RESEARCH AND OPINION, cilt.16, sa.4, ss.296-306, 2001
dc.identifier.issn0300-7995
dc.identifier.othervv_1032021
dc.identifier.otherav_681cbb9d-bbd7-478e-9c21-45e0d692f7be
dc.identifier.urihttp://hdl.handle.net/20.500.12627/72213
dc.identifier.urihttps://doi.org/10.1185/030079901750120231
dc.description.abstractAim: To compare the effect of acarbose and gliclazide on clinical findings, biochemical parameters and safety in type 2 diabetic patients insufficiently controlled with medical nutrition therapy (MNT).
dc.language.isoeng
dc.subjectTıbbi Ekoloji ve Hidroklimatoloji
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectTıp
dc.subjectTIP, ARAŞTIRMA VE DENEYSEL
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectTIP, GENEL & İÇECEK
dc.subjectDahili Tıp Bilimleri
dc.titleComparison of acarbose and gliclazide as first-line agents in patients with type 2 diabetes
dc.typeMakale
dc.relation.journalCURRENT MEDICAL RESEARCH AND OPINION
dc.contributor.department, ,
dc.identifier.volume16
dc.identifier.issue4
dc.identifier.startpage296
dc.identifier.endpage306
dc.contributor.firstauthorID127179


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record